
Life Sciences Must Embrace New, Flexible Workflows To Grow
Lessons learned from the COVID-19 pandemic can help build companies' talent pools and lead to more agile workforce management.
The last year has been transformational for the life sciences industry. Thrust into the spotlight due to the COVID-19 pandemic, the sector responded by ramping up production of PPE, testing kits and ventilators while simultaneously developing highly effective coronavirus vaccines in record time, boosting public
Life science talent leaders deserve their share of credit for the many accomplishments the sector achieved in the last year. From maintaining business continuity by shifting employees to remote work when feasible, while simultaneously implementing safety measures for those who needed to continue to work onsite, talent agility has been critical. In fact,
The biggest issue is the difficulty in finding and attracting top talent who possess the skills life science companies need most. A recent Department of Defense
This problem is not new. Two years ago, even before the pandemic, experts were
So how can life science organizations address these issues? First, the sector must change the way it approaches flexible work arrangements. While most industries forecast an increase in their virtual workforces by the end of the year, life sciences companies only anticipate a slight uptick in remote work in 2021, even though 72 percent of life sciences leaders surveyed said they believed flexible working arrangements were critical to talent attraction.
By embracing virtual and more flexible work models, including contingent talent, the life sciences sector will not only dramatically increase their available talent pool beyond their local geographic area, but they will avoid missing out on highly skilled workers who could be snapped up by competitors who embrace flexibility more fully.
Additionally, the Talent Trends research found that the life sciences sector also lags behind other industries surveyed when it comes to the overall talent experience, an area that must be improved if the sector wants to compete for, engage with and ultimately retain the best candidates.
One way to address this issue that would help companies both from a workforce and business perspective is to invest more aggressively in upskilling and reskilling opportunities for employees. On the talent side, helping workers improve their skills and competencies not only helps companies retain top talent, but also allows businesses to attract workers who want to work for an organization that provides growth opportunities and invests in their future. From a business perspective, offering robust reskilling and upskilling opportunities allows organizations to close their skills gaps and ensures their workforce is armed with the competencies they know will be most needed in the short and long-term.
As evidenced by their response to the COVID-19 pandemic, there is no doubt that the life sciences industry is one of the most cutting-edge sectors in the world. Yet the industry also has an opportunity to adapt their approach to talent, particularly in regard to addressing looming skills shortages, adopting key technological advances and implementing workforce flexibility practices that could accelerate their ability to innovate. It is critical that C-suite and talent leaders in the life sciences sector apply the lessons learned during the pandemic and embrace a more flexible, holistic talent approach that will help build their talent pool and skills pipeline, integrate critical emerging technologies and embrace a more agile approach to their workforce that will continue to facilitate innovation now and in the future.
Alp Perahya, Executive Vice President, Randstad Sourceright, North America
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.